NIH Study Suggests Aspirin Use Protects From ER-Positive Breast Cancer
This article was originally published in The Tan Sheet
Executive Summary
Nonsteroidal anti-inflammatory drugs do not influence total breast cancer risk, but daily aspirin use appears to offer some protection from a type of the condition - estrogen receptor-positive - that responds to hormonal treatment, according to a National Institutes of Health study